Innovating Works
MELASTOP: Discovery of mevalonate and UBIAD1 inhibitors as novel drugs targeting melanoma skin cancer UNIVERSITA DEGLI STUDI DI PADOVA tramitó un H2020: ERC-2020-PoC Melanoma is the most aggressive skin tumor, extremely difficult to treat and with high mortality rate. Overcoming reduced sensitivity and ac...
2020-12-14 - 2024-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.